The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Intravitreal Injectable Market Research Report 2021

Global Intravitreal Injectable Market Research Report 2021

Publishing Date : Feb, 2021

License Type :
 

Report Code : 1605516

No of Pages : 96

Synopsis
Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.

Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.

North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.

The global Intravitreal Injectable market was valued at US$ 13720 million in 2020 and is expected to reach US$ 21960 million by the end of 2027, growing at a CAGR of 7.1% during 2021-2027.

This report focuses on Intravitreal Injectable volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Intravitreal Injectable market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Intravitreal Injectable Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Drug

  • Anti-VEGF
  • Steroids
  • Others

Segment by Disease

  • Macular Degeneration
  • Macular Edema
  • Uveitis
  • Retinal Vein Occlusion
  • Others

By Region

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, Other Regions)
  • Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, U.A.E., South Africa, Other Regions)

By Company

  • Regeneron Pharmaceuticals (Eylea)
  • Allergan
  • EyePoint Pharmaceuticals
  • Genentech
  • Kanghong Pharmaceutical

Scope of the Intravitreal Injectable Market Report

Report Metric

Details

Report Name

Intravitreal Injectable Market

Market size in 2020

US$ 13720 Million

The revenue forecast in 2027

US$ 21960 Million

Growth Rate

CAGR of 7.1% from 2021 to 2027

Market size available for years

2020-2027

Forecast units

Value (USD) & Volume (Units)

Segments covered

Types, End-User / Applications, Companies, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

Index

1 Intravitreal Injectable Market Overview
1.1 Product Overview and Scope of Intravitreal Injectable
1.2 Intravitreal Injectable Segment by Drug
1.2.1 Global Intravitreal Injectable Sales Growth Rate Comparison by Drug (2021-2027)
1.2.2 Anti-VEGF
1.2.3 Steroids
1.2.4 Others
1.3 Intravitreal Injectable Segment by Disease
1.3.1 Global Intravitreal Injectable Sales Comparison by Disease: (2021-2027)
1.3.2 Macular Degeneration
1.3.3 Macular Edema
1.3.4 Uveitis
1.3.5 Retinal Vein Occlusion
1.3.6 Others
1.4 Global Intravitreal Injectable Market Size Estimates and Forecasts
1.4.1 Global Intravitreal Injectable Revenue 2016-2027
1.4.2 Global Intravitreal Injectable Sales 2016-2027
1.4.3 Intravitreal Injectable Market Size by Region: 2016 Versus 2021 Versus 2027

2 Intravitreal Injectable Market Competition by Manufacturers
2.1 Global Intravitreal Injectable Sales Market Share by Manufacturers (2016-2021)
2.2 Global Intravitreal Injectable Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Intravitreal Injectable Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Intravitreal Injectable Manufacturing Sites, Area Served, Product Type
2.5 Intravitreal Injectable Market Competitive Situation and Trends
2.5.1 Intravitreal Injectable Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Intravitreal Injectable Players Market Share by Revenue
2.5.3 Global Intravitreal Injectable Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Intravitreal Injectable Retrospective Market Scenario by Region
3.1 Global Intravitreal Injectable Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Intravitreal Injectable Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Intravitreal Injectable Market Facts & Figures by Country
3.3.1 North America Intravitreal Injectable Sales by Country
3.3.2 North America Intravitreal Injectable Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Intravitreal Injectable Market Facts & Figures by Country
3.4.1 Europe Intravitreal Injectable Sales by Country
3.4.2 Europe Intravitreal Injectable Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Intravitreal Injectable Market Facts & Figures by Region
3.5.1 Asia Pacific Intravitreal Injectable Sales by Region
3.5.2 Asia Pacific Intravitreal Injectable Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Intravitreal Injectable Market Facts & Figures by Country
3.6.1 Latin America Intravitreal Injectable Sales by Country
3.6.2 Latin America Intravitreal Injectable Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Intravitreal Injectable Market Facts & Figures by Country
3.7.1 Middle East and Africa Intravitreal Injectable Sales by Country
3.7.2 Middle East and Africa Intravitreal Injectable Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Intravitreal Injectable Historic Market Analysis by Drug
4.1 Global Intravitreal Injectable Sales Market Share by Drug (2016-2021)
4.2 Global Intravitreal Injectable Revenue Market Share by Drug (2016-2021)
4.3 Global Intravitreal Injectable Price by Drug (2016-2021)

5 Global Intravitreal Injectable Historic Market Analysis by Disease
5.1 Global Intravitreal Injectable Sales Market Share by Disease (2016-2021)
5.2 Global Intravitreal Injectable Revenue Market Share by Disease (2016-2021)
5.3 Global Intravitreal Injectable Price by Disease (2016-2021)

6 Key Companies Profiled
6.1 Regeneron Pharmaceuticals (Eylea)
6.1.1 Regeneron Pharmaceuticals (Eylea) Corporation Information
6.1.2 Regeneron Pharmaceuticals (Eylea) Description and Business Overview
6.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Portfolio
6.1.5 Regeneron Pharmaceuticals (Eylea) Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Intravitreal Injectable Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Allergan Intravitreal Injectable Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 EyePoint Pharmaceuticals
6.3.1 EyePoint Pharmaceuticals Corporation Information
6.3.2 EyePoint Pharmaceuticals Description and Business Overview
6.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Revenue and Gross Margin (2016-2021)
6.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Product Portfolio
6.3.5 EyePoint Pharmaceuticals Recent Developments/Updates
6.4 Genentech
6.4.1 Genentech Corporation Information
6.4.2 Genentech Description and Business Overview
6.4.3 Genentech Intravitreal Injectable Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Genentech Intravitreal Injectable Product Portfolio
6.4.5 Genentech Recent Developments/Updates
6.5 Kanghong Pharmaceutical
6.5.1 Kanghong Pharmaceutical Corporation Information
6.5.2 Kanghong Pharmaceutical Description and Business Overview
6.5.3 Kanghong Pharmaceutical Intravitreal Injectable Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Kanghong Pharmaceutical Intravitreal Injectable Product Portfolio
6.5.5 Kanghong Pharmaceutical Recent Developments/Updates

7 Intravitreal Injectable Manufacturing Cost Analysis
7.1 Intravitreal Injectable Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Intravitreal Injectable
7.4 Intravitreal Injectable Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Intravitreal Injectable Distributors List
8.3 Intravitreal Injectable Customers

9 Intravitreal Injectable Market Dynamics
9.1 Intravitreal Injectable Industry Trends
9.2 Intravitreal Injectable Growth Drivers
9.3 Intravitreal Injectable Market Challenges
9.4 Intravitreal Injectable Market Restraints

10 Global Market Forecast
10.1 Intravitreal Injectable Market Estimates and Projections by Drug
10.1.1 Global Forecasted Sales of Intravitreal Injectable by Drug (2022-2027)
10.1.2 Global Forecasted Revenue of Intravitreal Injectable by Drug (2022-2027)
10.2 Intravitreal Injectable Market Estimates and Projections by Disease
10.2.1 Global Forecasted Sales of Intravitreal Injectable by Disease (2022-2027)
10.2.2 Global Forecasted Revenue of Intravitreal Injectable by Disease (2022-2027)
10.3 Intravitreal Injectable Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Intravitreal Injectable by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Intravitreal Injectable by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Intravitreal Injectable Sales (K Units) Growth Rate Comparison by Drug (2021-2027)
Table 2. Global Intravitreal Injectable Sales (K Units) Comparison by Disease (2021-2027)
Table 3. Global Intravitreal Injectable Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Intravitreal Injectable Covered in This Study
Table 5. Global Intravitreal Injectable Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Intravitreal Injectable Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Intravitreal Injectable Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Intravitreal Injectable Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Intravitreal Injectable Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Intravitreal Injectable Manufacturing Sites and Area Served
Table 11. Manufacturers Intravitreal Injectable Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Intravitreal Injectable by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravitreal Injectable as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Intravitreal Injectable Sales by Region (2016-2021) & (K Units)
Table 16. Global Intravitreal Injectable Sales Market Share by Region (2016-2021)
Table 17. Global Intravitreal Injectable Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Intravitreal Injectable Sales by Country (2016-2021) & (K Units)
Table 19. North America Intravitreal Injectable Sales Market Share by Country (2016-2021)
Table 20. North America Intravitreal Injectable Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Intravitreal Injectable Revenue Market Share by Country (2016-2021)
Table 22. Europe Intravitreal Injectable Sales by Country (2016-2021) & (K Units)
Table 23. Europe Intravitreal Injectable Sales Market Share by Country (2016-2021)
Table 24. Europe Intravitreal Injectable Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Intravitreal Injectable Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Intravitreal Injectable Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Intravitreal Injectable Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Intravitreal Injectable Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Intravitreal Injectable Revenue Market Share by Region (2016-2021)
Table 30. Latin America Intravitreal Injectable Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Intravitreal Injectable Sales Market Share by Country (2016-2021)
Table 32. Latin America Intravitreal Injectable Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Intravitreal Injectable Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Intravitreal Injectable Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Intravitreal Injectable Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Intravitreal Injectable Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Intravitreal Injectable Revenue Market Share by Country (2016-2021)
Table 38. Global Intravitreal Injectable Sales (K Units) by Drug (2016-2021)
Table 39. Global Intravitreal Injectable Sales Market Share by Drug (2016-2021)
Table 40. Global Intravitreal Injectable Revenue (Million US$) by Drug (2016-2021)
Table 41. Global Intravitreal Injectable Revenue Share by Drug (2016-2021)
Table 42. Global Intravitreal Injectable Price (US$/Unit) by Drug (2016-2021)
Table 43. Global Intravitreal Injectable Sales (K Units) by Disease (2016-2021)
Table 44. Global Intravitreal Injectable Sales Market Share by Disease (2016-2021)
Table 45. Global Intravitreal Injectable Revenue (Million US$) by Disease (2016-2021)
Table 46. Global Intravitreal Injectable Revenue Share by Disease (2016-2021)
Table 47. Global Intravitreal Injectable Price (US$/Unit) by Disease (2016-2021)
Table 48. Regeneron Pharmaceuticals (Eylea) Corporation Information
Table 49. Regeneron Pharmaceuticals (Eylea) Description and Business Overview
Table 50. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product
Table 52. Regeneron Pharmaceuticals (Eylea) Recent Developments/Updates
Table 53. Allergan Corporation Information
Table 54. Allergan Description and Business Overview
Table 55. Allergan Intravitreal Injectable Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Allergan Intravitreal Injectable Product
Table 57. Allergan Recent Developments/Updates
Table 58. EyePoint Pharmaceuticals Corporation Information
Table 59. EyePoint Pharmaceuticals Description and Business Overview
Table 60. EyePoint Pharmaceuticals Intravitreal Injectable Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. EyePoint Pharmaceuticals Intravitreal Injectable Product
Table 62. EyePoint Pharmaceuticals Recent Developments/Updates
Table 63. Genentech Corporation Information
Table 64. Genentech Description and Business Overview
Table 65. Genentech Intravitreal Injectable Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Genentech Intravitreal Injectable Product
Table 67. Genentech Recent Developments/Updates
Table 68. Kanghong Pharmaceutical Corporation Information
Table 69. Kanghong Pharmaceutical Description and Business Overview
Table 70. Kanghong Pharmaceutical Intravitreal Injectable Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Kanghong Pharmaceutical Intravitreal Injectable Product
Table 72. Kanghong Pharmaceutical Recent Developments/Updates
Table 73. Production Base and Market Concentration Rate of Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Intravitreal Injectable Distributors List
Table 76. Intravitreal Injectable Customers List
Table 77. Intravitreal Injectable Market Trends
Table 78. Intravitreal Injectable Growth Drivers
Table 79. Intravitreal Injectable Market Challenges
Table 80. Intravitreal Injectable Market Restraints
Table 81. Global Intravitreal Injectable Sales Forecast by Drug (2022-2027) & (K Units)
Table 82. Global Intravitreal Injectable Sales Market Share Forecast by Drug (2022-2027)
Table 83. Global Intravitreal Injectable Revenue Forecast by Drug (2022-2027) & (US$ Million)
Table 84. Global Intravitreal Injectable Revenue Market Share Forecast by Drug (2022-2027)
Table 85. Global Intravitreal Injectable Sales Forecast by Disease (2022-2027) & (K Units)
Table 86. Global Intravitreal Injectable Sales Market Share Forecast by Disease (2022-2027)
Table 87. Global Intravitreal Injectable Revenue Forecast by Disease (2022-2027) & (US$ Million)
Table 88. Global Intravitreal Injectable Revenue Market Share Forecast by Disease (2022-2027)
Table 89. Global Intravitreal Injectable Sales Forecast by Region (2022-2027) & (K Units)
Table 90. Global Intravitreal Injectable Sales Market Share Forecast by Region (2022-2027)
Table 91. Global Intravitreal Injectable Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 92. Global Intravitreal Injectable Revenue Market Share Forecast by Region (2022-2027)
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Intravitreal Injectable
Figure 2. Global Intravitreal Injectable Market Share by Drug in 2020 & 2027
Figure 3. Anti-VEGF Product Picture
Figure 4. Steroids Product Picture
Figure 5. Others Product Picture
Figure 6. Global Intravitreal Injectable Market Share by Disease in 2020 & 2027
Figure 7. Macular Degeneration
Figure 8. Macular Edema
Figure 9. Uveitis
Figure 10. Retinal Vein Occlusion
Figure 11. Others
Figure 12. Global Intravitreal Injectable Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Intravitreal Injectable Market Size 2016-2027 (US$ Million)
Figure 14. Global Intravitreal Injectable Sales 2016-2027 (K Units)
Figure 15. Global Intravitreal Injectable Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Intravitreal Injectable Sales Share by Manufacturers in 2020
Figure 17. Global Intravitreal Injectable Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Intravitreal Injectable Players: Market Share by Revenue in 2020
Figure 19. Intravitreal Injectable Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Intravitreal Injectable Sales Market Share by Region (2016-2021)
Figure 21. Global Intravitreal Injectable Sales Market Share by Region in 2020
Figure 22. Global Intravitreal Injectable Revenue Market Share by Region (2016-2021)
Figure 23. Global Intravitreal Injectable Revenue Market Share by Region in 2020
Figure 24. United States Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. China Taiwan Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Intravitreal Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Intravitreal Injectable by Drug (2016-2021)
Figure 47. Sales Market Share of Intravitreal Injectable by Disease (2016-2021)
Figure 48. Sales Market Share of Intravitreal Injectable by Disease in 2020
Figure 49. Revenue Share of Intravitreal Injectable by Disease (2016-2021)
Figure 50. Revenue Share of Intravitreal Injectable by Disease in 2020
Figure 51. Manufacturing Cost Structure of Intravitreal Injectable
Figure 52. Manufacturing Process Analysis of Intravitreal Injectable
Figure 53. Intravitreal Injectable Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’